Search research articles
Contact Us
Filters
Showing results (81-90 of 333) with videos related to
Page
of 34
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
September 1, 1972
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen
G Mavligit, J U Gutterman, C M McBride, et al.
Cancer Research
|
February 1, 1983
Renal cell carcinoma: antitumor effects of leukocyte interferon
J R Quesada, D A Swanson, A Trindade, et al.
Cancer
|
June 1, 1982
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma
A Robidoux, J U Gutterman, G P Bodey, et al.
Oncogene
|
April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma
K Mujoo, D C Maneval, S C Anderson, et al.
Journal of Interferon Research
|
August 1, 1989
Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients
R Kurzrock, B Feinberg, M Talpaz, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1986
Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung
J C Liang, R Kurzrock, J U Gutterman, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 1, 1974
Cell-mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytes
G M Mavligit, J U Gutterman, E M Hersh, et al.
Cancer Research
|
May 1, 1988
Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration
E S Kleinerman, R D Knowles, L B Lachman, et al.
Annals of Internal Medicine
|
December 1, 1983
Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia
M Talpaz, G Mavligit, M Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure
R Kurzrock, M Talpaz, Z Estrov, et al.
Page
of 34
Search research articles
Search
Showing results (81-90 of 333) with videos related to
Sort By:
Page
of 34
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
September 1, 1972
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen
G Mavligit, J U Gutterman, C M McBride, et al.
Cancer Research
|
February 1, 1983
Renal cell carcinoma: antitumor effects of leukocyte interferon
J R Quesada, D A Swanson, A Trindade, et al.
Cancer
|
June 1, 1982
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma
A Robidoux, J U Gutterman, G P Bodey, et al.
Oncogene
|
April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma
K Mujoo, D C Maneval, S C Anderson, et al.
Journal of Interferon Research
|
August 1, 1989
Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients
R Kurzrock, B Feinberg, M Talpaz, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1986
Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung
J C Liang, R Kurzrock, J U Gutterman, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 1, 1974
Cell-mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytes
G M Mavligit, J U Gutterman, E M Hersh, et al.
Cancer Research
|
May 1, 1988
Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration
E S Kleinerman, R D Knowles, L B Lachman, et al.
Annals of Internal Medicine
|
December 1, 1983
Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia
M Talpaz, G Mavligit, M Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure
R Kurzrock, M Talpaz, Z Estrov, et al.
Page
of 34